Jim Simons’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-56,263
| Closed | -$375K | – | 3844 |
|
|
2025
Q3 | $375K | Buy |
56,263
+100
| +0.2% | +$674 | ﹤0.01% | 2911 |
|
|
2025
Q2 | $388K | Hold |
56,163
| – | – | ﹤0.01% | 2957 |
|
|
2025
Q1 | $380K | Sell |
56,163
-100
| -0.2% | -$700 | ﹤0.01% | 2840 |
|
|
2024
Q4 | $417K | Sell |
56,263
-1,500
| -3% | -$7.95K | ﹤0.01% | 2924 |
|
|
2024
Q3 | $302K | Buy |
57,763
+400
| +0.7% | +$2.12K | ﹤0.01% | 2979 |
|
|
2024
Q2 | $312K | Hold |
57,363
| – | – | ﹤0.01% | 2896 |
|
|
2024
Q1 | $373K | Sell |
57,363
-800
| -1% | -$7.14K | ﹤0.01% | 2994 |
|
|
2023
Q4 | $444K | Buy |
58,163
+1,600
| +3% | +$10.8K | ﹤0.01% | 2835 |
|
|
2023
Q3 | $338K | Buy |
56,563
+9,100
| +19% | +$93.5K | ﹤0.01% | 2878 |
|
|
2023
Q2 | $580K | Buy |
47,463
+1,065
| +2% | +$14.1K | ﹤0.01% | 2791 |
|
|
2023
Q1 | $818K | Buy |
46,398
+39,374
| +561% | +$2.03M | ﹤0.01% | 2604 |
|
|
2022
Q4 | $365K | Buy |
7,024
+3,581
| +104% | +$260K | ﹤0.01% | 3128 |
|
|
2022
Q3 | $289K | Sell |
3,443
-6,804
| -66% | -$903K | ﹤0.01% | 3227 |
|
|
2022
Q2 | $1.49M | Buy |
10,247
+5,544
| +118% | +$807K | ﹤0.01% | 2416 |
|
|
2022
Q1 | $726K | Sell |
4,703
-8,392
| -64% | -$1.86M | ﹤0.01% | 2940 |
|
|
2021
Q4 | $3.6M | Buy |
+13,095
| New | +$6.05M | ﹤0.01% | 1736 |
|
Jim Simons's NEUE Position: Q4 2025 in Review
Jim Simons sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 56,263 shares — an estimated $375K sold.
Jim Simons first reported a position in NEUE in Q4 2021 and held it in 16 quarters. The position peaked at $3.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- Jim Simons reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- Jim Simons sold 56,263 NeueHealth shares in Q4 2025, an estimated $375K.
- Jim Simons first reported a position in NeueHealth in Q4 2021 and held it in 16 quarters.
- Jim Simons's NeueHealth position peaked at $3.6M in Q4 2021.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.